May is Mental Health Month and Dr. Michael Jablonski, Ph.D., M.S., Vice President of Medical Affairs for the GeneSight test at Myriad Genetics, discusses the results of a new GeneSight Mental Health Monitor national poll that found that 83 percent of those diagnosed with depression say life would be easier if others could understand what they’re going through. He shares other findings from the poll and talks about treatment options.
Michael Jablonski, Ph.D., M.S, is the vice president of medical affairs for the GeneSight test at Myriad Genetics. Dr. Jabolnski leads clinician education for Myriad Neuroscience by providing strategic direction for the field medical and medical information teams. Dr. Jabolnski has an extensive background in neuroscience, genetics, personalized medicine, biotechnology, and academic research with multiple publications in the fields of psychiatry, pharmacogenomics, ALS, Parkinson’s disease, and sleep medicine. He holds multiple patents for novel treatments of neurodegenerative diseases. Dr. Jabolnski earned a Ph.D. in neuroscience from Thomas Jefferson University, a M.S. in medical sciences from Drexel University, and a B.A. in psychology from Northwestern University.